ATE88707T1 - Antagonisten fuer den platelet-aktivierungsfaktor, phomactine genannt, ihre herstellung und verwendung. - Google Patents

Antagonisten fuer den platelet-aktivierungsfaktor, phomactine genannt, ihre herstellung und verwendung.

Info

Publication number
ATE88707T1
ATE88707T1 AT89312361T AT89312361T ATE88707T1 AT E88707 T1 ATE88707 T1 AT E88707T1 AT 89312361 T AT89312361 T AT 89312361T AT 89312361 T AT89312361 T AT 89312361T AT E88707 T1 ATE88707 T1 AT E88707T1
Authority
AT
Austria
Prior art keywords
phomactins
called
antagonists
production
platelet activation
Prior art date
Application number
AT89312361T
Other languages
English (en)
Inventor
Aiya Sato
Michihiro Sugano
Kouhei Furuya
Takeshi Oshima
Harumitsu Kuwano
Tadashi Hata
Hideyuki Haruyama
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE88707T1 publication Critical patent/ATE88707T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT89312361T 1988-11-28 1989-11-28 Antagonisten fuer den platelet-aktivierungsfaktor, phomactine genannt, ihre herstellung und verwendung. ATE88707T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30027888 1988-11-28
EP89312361A EP0371762B1 (de) 1988-11-28 1989-11-28 Antagonisten für den Platelet-Aktivierungsfaktor, Phomactine genannt, ihre Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ATE88707T1 true ATE88707T1 (de) 1993-05-15

Family

ID=17882866

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89312361T ATE88707T1 (de) 1988-11-28 1989-11-28 Antagonisten fuer den platelet-aktivierungsfaktor, phomactine genannt, ihre herstellung und verwendung.

Country Status (7)

Country Link
US (1) US5151529A (de)
EP (1) EP0371762B1 (de)
KR (1) KR940004128B1 (de)
AT (1) ATE88707T1 (de)
CA (1) CA2003956A1 (de)
DE (1) DE68906248T2 (de)
ES (1) ES2055104T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663193A (en) * 1995-07-25 1997-09-02 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
AU706341B2 (en) * 1995-07-25 1999-06-17 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
JP4123106B2 (ja) 2003-08-22 2008-07-23 ソニー株式会社 有機ｅｌ素子

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6339591A (ja) * 1986-08-04 1988-02-20 Nippon Kayaku Co Ltd 新規生理活性物質ＮＫ−Ａ−１７−ｅ−２３３およびその製造法
JPS63307872A (ja) * 1987-06-09 1988-12-15 Nippon Kayaku Co Ltd 新規生理活性物質ＮＫ−Ａ−１７−ｅ−２３３−４およびその製造法

Also Published As

Publication number Publication date
ES2055104T3 (es) 1994-08-16
CA2003956A1 (en) 1990-05-28
DE68906248D1 (de) 1993-06-03
DE68906248T2 (de) 1993-08-12
EP0371762B1 (de) 1993-04-28
EP0371762A3 (de) 1991-03-20
US5151529A (en) 1992-09-29
EP0371762A2 (de) 1990-06-06
KR900008048A (ko) 1990-06-02
KR940004128B1 (ko) 1994-05-13

Similar Documents

Publication Publication Date Title
ES2124479T3 (es) Composiciones biocidas.
BG103590A (en) Pesticide 1-arylpyrazols
AU671818B2 (en) Halichondrins
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
ATE212860T1 (de) Eine neuartige medizinische verwendung eines 5ht 3-antagonisten
DE69302508D1 (de) Taxanderivate, ihre Herstellung und ihre Anwendung in der Onkologie
EP0318084A3 (de) Benzoheterazole
FR2684103B1 (fr) Nouveaux composes a structure guanidique et composition pharmaceutique les contenant.
TW257750B (de)
IT1212143B (it) Composizione ad attivita'tricogena.
DE58904434D1 (de) Organische derivate von rheniumoxiden sowie ihre herstellung und verwendung zur metathese von olefinen.
ATE113591T1 (de) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
DE68906248D1 (de) Antagonisten fuer den platelet-aktivierungsfaktor, phomactine genannt, ihre herstellung und verwendung.
ATE102188T1 (de) Benzazepinderivate.
AP8800109A0 (en) "Heterocyclic insecticides".
DE3751362D1 (de) 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva.
ATE45739T1 (de) Indolophenanthridine, ihre herstellung und verwendung.
EP0354184A3 (de) Substituierte Piperidinverbindungen und ihrer Verwendung als Stabilisatoren für organische Materialien
KR920703050A (ko) 골형성 촉진제
DE68903907D1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
DE3582890D1 (de) 2-oxindolzwischenprodukte.
DE69333302D1 (de) Mikroorganismen, ihre herstellung und verwendung
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
WO1990007260A3 (en) 2,3-methanoproline
AU4486589A (en) N-sulfenylated and n-acylated pyrazolines

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee